These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29861174)

  • 21. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
    Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets.
    Narayanan BA; Narayanan NK; Re GG; Nixon DW
    Int J Cancer; 2003 Mar; 104(2):204-12. PubMed ID: 12569576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.
    Nadiminty N; Lou W; Sun M; Chen J; Yue J; Kung HJ; Evans CP; Zhou Q; Gao AC
    Cancer Res; 2010 Apr; 70(8):3309-19. PubMed ID: 20388792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.
    Araki S; Omori Y; Lyn D; Singh RK; Meinbach DM; Sandman Y; Lokeshwar VB; Lokeshwar BL
    Cancer Res; 2007 Jul; 67(14):6854-62. PubMed ID: 17638896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-kappaB regulates androgen receptor expression and prostate cancer growth.
    Zhang L; Altuwaijri S; Deng F; Chen L; Lal P; Bhanot UK; Korets R; Wenske S; Lilja HG; Chang C; Scher HI; Gerald WL
    Am J Pathol; 2009 Aug; 175(2):489-99. PubMed ID: 19628766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent state.
    Nadendla SK; Hazan A; Ward M; Harper LJ; Moutasim K; Bianchi LS; Naase M; Ghali L; Thomas GJ; Prowse DM; Philpott MP; Neill GW
    PLoS One; 2011; 6(5):e20271. PubMed ID: 21633508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P53 and the proteasome regulate androgen receptor activity.
    Guseva NV; Rokhlin OW; Glover RA; Cohen MB
    Cancer Biol Ther; 2012 May; 13(7):553-8. PubMed ID: 22407029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer.
    Rokhlin OW; Scheinker VS; Taghiyev AF; Bumcrot D; Glover RA; Cohen MB
    Cancer Biol Ther; 2008 Aug; 7(8):1288-96. PubMed ID: 18497571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and the molecular forms of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase 9 in canine mammary tumours.
    Chen YC; Chang SC; Huang YH; Lee YJ; Chang CC; Liao JW; Hsu WL
    Vet Comp Oncol; 2019 Sep; 17(3):427-438. PubMed ID: 31050171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
    Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y
    Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells.
    Iannetti A; Pacifico F; Acquaviva R; Lavorgna A; Crescenzi E; Vascotto C; Tell G; Salzano AM; Scaloni A; Vuttariello E; Chiappetta G; Formisano S; Leonardi A
    Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14058-63. PubMed ID: 18768801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [NF-κB subunits regulate maspin expression in prostate cancer cells in vitro].
    Ma L; Shen YY; Zhou P; Zhou J; Guo F
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):165-8. PubMed ID: 22780967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-kappaB.
    Raj GV; Sekula JA; Guo R; Madden JF; Daaka Y
    Prostate; 2004 Oct; 61(2):105-13. PubMed ID: 15305333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha.
    Cowland JB; Sørensen OE; Sehested M; Borregaard N
    J Immunol; 2003 Dec; 171(12):6630-9. PubMed ID: 14662866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
    Trtková K; Pašková L; Matiješčuková N; Kolář Z
    Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of androgen receptors by NaAsO
    Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS
    Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.
    Sarwar M; Sandberg S; Abrahamsson PA; Persson JL
    Urol Oncol; 2014 Jan; 32(1):25.e1-12. PubMed ID: 23410945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.
    Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T
    Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.